The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...

Please provide your email address to receive an email when new articles are posted on . The Advisory Committee on Immunization Practices recently released its 2018 adult immunization schedule, which ...

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was ...

Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout. While Shingrix sales are churning ahead of ...

If you've ever had chickenpox, you are at risk of developing shingles in the future. While people might assume that shingles — a painful, blistering rash — only affects older adults, 1 in 3 ...

Shingles can be a nasty experience, leaving its victims with severe pain, blisters, itching and scarring. Almost one of every three people in the United States will develop shingles, also known as ...

Sign up for the CommonHealth newsletter to receive a weekly digest of WBUR's best health, medicine and science coverage. If you're 50 or older, Judith Strull's story ...

GSK has received the Food and Drug Administration’s approval for a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster).

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...